MOMarcella E. O'REilly

Marcella E. O'REilly

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marcella E. O'REilly has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Conjugated Linoleic Acid and Alpha Linolenic Acid Improve Cholesterol Homeostasis in Obesity by Modulating Distinct Hepatic Protein Pathways

    by Marcella E. O'REilly, Yvonne M. Lenighan, Eugene Dillon, Sarina Kajani, Sean Curley, Robyn Bruen, Rachel Byrne, Aoibhin Moore Heslin, Aidan P. Moloney, Helen M. Roche, et al.

    Scope: High‐fat diet (HFD)‐induced obesity impairs macrophage‐to‐feces reverse cholesterol transport (RCT). It is hypothesized that dietary supplementation with the polyunsaturated fatty acids conjugated linoleic acid (CLA) or alpha linolenic acid (ALA) would prevent HFD‐impaired RCT by modulating hepatic protein pathways.Methods and results: ApoE3L.CETP mice are fed a HFD supplemented ± CLA or ALA for 12 weeks and in vivo macrophage‐to‐feces RCT is determined. Hepatic cholesterol transporters and the hepatic proteome are assessed by immunoblotting and mass spectrometry, respectively. Mice fed HFD alone, but not ALA‐HFD or CLA‐HFD, exhibit increased systemic cholesterol levels, increased 3H‐cholesterol levels in plasma and liver but not feces during RCT, and reduced hepatic ABCG5/8 expression relative to LFD. ALA‐HFD significantly reduces liver weight, hepatic cholesterol levels, and expression of the cholesterol synthesis enzyme farnesyl pyrophosphate synthase relative to HFD. ALA further increases the expression of acetyl‐coA oxidase‐associated proteins and suppress PPARα‐induced proteins relative to HFD. CLA does not significantly attenuate hepatic lipid levels but is associated with reduced hepatic expression of fatty acid binding protein (FABP)‐1/FABP4 levels relative to HFD, and reduced inflammatory pathway activation relative to ALA‐HFD.Conclusion: ALA and CLA exert distinct mechanistic advantages on cholesterol homeostasis and RCT in obesity.


  • Open Access

    Nutritionally Derived Metabolic Cues Typical of the Obese Microenvironment Increase Cholesterol Efflux Capacity of Adipose Tissue Macrophages

    by Marcella E. O'REilly, Sarina Kajani, Jessica C. Ralston, Yvonne M. Lenighan, Helen M. Roche, Fiona C. McGillicuddy

    Background: Cholesterol retention within plasma membranes of macrophages is associated with increased inflammatory signaling. Cholesterol efflux via the transporters ABCA1, ABCG1, and SR‐BI to high‐density lipoprotein (HDL) particles is a critical mechanism to maintain cellular cholesterol homeostasis. Little is known about the impact of the obese microenvironment on cholesterol efflux capacity (CEC) of macrophages. In this study, the CEC of obese‐derived primary adipose‐tissue macrophages (ATM) is evaluated and the in vivo microenvironment is modeled in vitro to determine mechanisms underlying modulated CEC.Materials and Methods: F4/80+ ATM are labeled with 3H‐cholesterol ex vivo, and CEC and ABCA1/ABCG1 protein levels are determined. Total, ABCA1‐dependent, and ABCA1‐independent CECs are determined in J774 macrophages polarized to M1 (LPS&IFNγ), M2 (IL‐4&IL‐13), or metabolic phenotypes (glucose, insulin, and palmitic acid).Results: Obese ATM exhibit enhanced CEC and ABCA1 and ABCG1 expression compared to lean ATM. In contrast, ABCA1‐CEC is suppressed from M1 polarized macrophages compared to untreated in vitro, by activation of the JAK/STAT pathway. Incubation of macrophages in vitro in high glucose augments cAMP‐induced ABCA1 protein expression and ABCA1‐CEC.Conclusions: These novel findings demonstrate remarkable plasticity of macrophages to respond to their environment with specific modulation of ABCA1 depending on whether classical pro‐inflammatory or metabolic cues predominate.


  • Nutritional modulation of metabolic inflammation

    by Anna M. Kirwan, Yvonne M. Lenighan, Marcella E. O'REilly, Fiona C. McGillicuddy, Helen M. Roche

    Metabolic inflammation is a very topical area of research, wherein aberrations in metabolic and inflammatory pathways probably contribute to atherosclerosis, insulin resistance (IR) and type 2 diabetes. Metabolic insults arising from obesity promote inflammation, which in turn impedes insulin signalling and reverse cholesterol transport (RCT). Key cells in the process are metabolically activated macrophages, which up-regulate both pro- and anti-inflammatory pathways in response to lipid spillover from adipocytes. Peroxisome proliferator-activated receptors and AMP-activated protein kinase (AMPK) are regulators of cellular homeostasis that influence both inflammatory and metabolic pathways. Dietary fats, such as saturated fatty acids (SFAs), can differentially modulate metabolic inflammation. Palmitic acid, in particular, is a well-characterized nutrient that promotes metabolic inflammation via the NLRP3 (the nod-like receptor containing a pyrin domain) inflammasome, which is partly attributable to AMPK inhibition. Conversely, some unsaturated fatty acids are less potent agonists of metabolic inflammation. For example, monounsaturated fatty acid does not reduce AMPK as potently as SFA and n-3 polyunsaturated fatty acids actively resolve inflammation via resolvins and protectins. Nevertheless, the full extent to which nutritional state modulates metabolic inflammation requires greater clarification.


  • Total HDL cholesterol efflux capacity in healthy children – Associations with adiposity and dietary intakes of mother and child

    by H. Khalil, C. Murrin, M. O'Reilly, K. Viljoen, R. Segurado, J. O'Brien, R. Somerville, F. McGillicuddy, C.C. Kelleher


  • Open Access

    High-Density Lipoprotein Proteomic Composition, and not Efflux Capacity, Reflects Differential Modulation of Reverse Cholesterol Transport by Saturated and Monounsaturated Fat Diets

    by Marcella O’rEilly, Eugene Dillon, Weili Guo, Orla Finucane, Aoibheann McMorrow, Aoife Murphy, Claire Lyons, Daniel Jones, Miriam Ryan, Michael Gibney, et al.

    Background—: Acute inflammation impairs reverse cholesterol transport (RCT) and reduces high-density lipoprotein (HDL) function in vivo. This study hypothesized that obesity-induced inflammation impedes RCT and alters HDL composition, and investigated if dietary replacement of saturated (SFA) for monounsaturated (MUFA) fatty acids modulates RCT. Methods and Results—: Macrophage-to-feces RCT, HDL efflux capacity, and HDL proteomic profiling was determined in C57BL/6j mice following 24 weeks on SFA- or MUFA-enriched high-fat diets (HFDs) or low-fat diet. The impact of dietary SFA consumption and insulin resistance on HDL efflux function was also assessed in humans. Both HFDs increased plasma 3 H-cholesterol counts during RCT in vivo and ATP-binding cassette, subfamily A, member 1–independent efflux to plasma ex vivo, effects that were attributable to elevated HDL cholesterol. By contrast, ATP-binding cassette, subfamily A, member 1–dependent efflux was reduced after both HFDs, an effect that was also observed with insulin resistance and high SFA consumption in humans. SFA-HFD impaired liver-to-feces RCT, increased hepatic inflammation, and reduced ABC subfamily G member 5/8 and ABC subfamily B member 11 transporter expression in comparison with low-fat diet, whereas liver-to-feces RCT was preserved after MUFA-HFD. HDL particles were enriched with acute-phase proteins (serum amyloid A, haptoglobin, and hemopexin) and depleted of paraoxonase-1 after SFA-HFD in comparison with MUFA-HFD. Conclusions—: Ex vivo efflux assays validated increased macrophage-to-plasma RCT in vivo after both HFDs but failed to capture differential modulation of hepatic cholesterol trafficking. By contrast, proteomics revealed the association of hepatic-derived inflammatory proteins on HDL after SFA-HFD in comparison with MUFA-HFD, which reflected differential hepatic cholesterol trafficking between groups. Acute-phase protein levels on HDL may serve as novel biomarkers of impaired liver-to-feces RCT in vivo.


  • Fatty acid manipulation of obesity – consequences for high-density lipoprotein protein composition and macrophage-to-feces reverse cholesterol transport (rct)

    by M. O'REilly, O. Finucane, D. Jones, A. Murphy, C. Lyons, M. de la Llera Moya, M.P. Reilly, H.M. Roche, F.C. McGillicuddy